How much will the Artificial Ventilation and Anesthesia Masks industry be worth in the Future????
Global artificial
ventilation and anesthesia masks market
is expected to reach USD 2,888.8 million
by 2022, according to a new report by Grand View Research, Inc. Key factors
attributing to market growth include rising number of operation and emergency
room procedures coupled with growing demand novel products which can be used to
carry out intubation process without removing the oxygen mask. Increase in the
target disease has a direct impact on the number of operation room, emergency
and intensive care procedures and is expected to boost usage rates of
ventilation masks over the forecast period.
A rapid increase in the demand for
supplemental oxygen therapy, as a consequence of the Covid-19 outbreak, the
artificial ventilation masks market is experiencing a unique challenge of
supply shortage. However, the development of makeshift 3D printed masks is catering
to this exponential increase in the demand. We at GVR are trying to quantify
the impact of this pandemic on the artificial ventilation masks market. Get you
to copy now to gain deeper insights on the same.
Increasing geriatric population is a
major factor increasing the prevalence rate of several diseases. Additionally,
growing prevalence of sleep apnea is one of the most significant growth drivers
for these anesthesia and ventilation masks over the forecast period.
In the artificial ventilation and anesthesia masks market,
Phillips Respironics is the market leader as it has very strong financial
performance, wide product portfolio and it also ranks very high on regional
penetration. Some of its key products
include Wisp, ComfortGel blue nasal mask, amara full view mask, and Easy life
CPAP masks. Key market participants include players such as ResMed, Fisher and
Paykel, Ambu, Drager, and CareFusion. Furthermore, increasing technological
advancements leading to the development of novel products such as SuperNO2VA by
which can be used for the administration of anesthesia, during intubation and
assisted breathing process for patients suffering from sleep apnea are expected
to further intensify the competition over the forecast period.
According to statistics published by
the National Sleep Foundation in 2012, around 40 million Americans were
affected by chronic sleep disorders. Furthermore, these patients are at a high
risk of visiting emergency department and intensive care units, and as a
consequence are expected to increase the demand of ventilation masks in the
next seven years.
To Request Sample Copy of this report, click the link:
The market dynamics indicate that
various players operating in this space compete on the basis of product
specification and prices. The technology used to manufacture, quality of the
product, and patient comfort are the key variables expected to impact the usage
of these products. The healthcare providers assess the risk to the patient and
determine the need to use invasive ventilation or non-invasive ventilation. The
use of non invasive masks in accident and trauma cases, lung failure and other
emergency cases is a key factor contributing to the high usage rates of these
products.
The market is segmented on the basis
of application as operation room, intensive care units, emergency room, dental,
and home care. In 2014 operating room held the maximum share of over 58% for
low risk procedures and is expected to be the largest segment in the next seven
years. Increase in insurance penetration, number of hospitals and dental
centers to tap the high unmet needs in emerging economies is a key factor
expected to boost the surgical volume and therefore these factors are expected
to increase the demand for ventilation masks over the forecast period.
Further key findings
from the report suggest:
·
In 2014, North America dominated the
overall market with a share of more than 50%. Key factors attributing to its
large share include presence of robust healthcare infrastructure, which
includes hospitals, emergency and dental centers.
·
Furthermore, in the U.S., the Affordable
Care Act is a key driver encouraging millions of patients to opt for surgical
treatments and utilize other healthcare services, and as a result is expected
to boost usage rates of artificial ventilation and anesthesia masks over the
forecast period.
·
Asia Pacific is expected to be the fastest
growing market over the forecast period. Key factors attributing to its high
growth are increase in public and private healthcare expenditure to build new
hospitals, improve reimbursement scenario which lead to improvement in overall
healthcare indicators.
·
Additionally, large population affected
with various diseases is expected to increase the number of emergency, ICU and
operating room procedures and as a result are expected to increase usage rates
in these markets.
·
Key players operating in the market include
Phillips Respironics, ResMed, Fisher & Paykel, CareFusion, Ambu, Drager,
and others. These companies have an extensive portfolio of ventilation and CPAP
masks.
·
Additionally, emergence of new players with
novel product offerings such as SuperNO2VA from RMDevices is expected change
market dynamics due to its ability to carry out inhalation anesthesia,
artificial ventilation and intubation procedure simultaneously.
Global
artificial ventilation and anesthesia masks market size was valued at USD
1,715.3 million in 2014. Key application areas of these masks include operation
room, emergency room, intensive care units, and dental rooms for intubation,
sedation, and assisted respiratory procedures.
Rising
geriatric population prone to various diseases, increasing emergency room
procedures, and the growth of home care health services are amongst key drivers
attributing to the market growth. Furthermore, availability of various
ventilation masks available in the market which include full face masks, nasal
masks, hybrid masks, oral masks and nasal pillows are going to provide patients
suffering from sleep apnea with a wide variety of products to choose from thus
boosting market growth.
According
to estimates published by the United Nations in 2012, the global geriatric
population was nearly 809.4 million and is expected to grow more than double by
2050 to reach an estimated population of over 2,000 million. The growth in
geriatric population is a major factor contributing to high prevalence rates of
various diseases such as COPD, sleep apnea cancers, coronary artery diseases,
kidney failures, and others.
The
impact of growing geriatric population on COPD prevalence is very high and as
per the WHO estimates, COPD is predicted to be the third leading cause of death
worldwide. In the U.S. alone, there were approximately 12.7 million adults aged
over 18 reported to have COPD. Increasing need of emergency treatment for
prolonged illnesses and long-term home care treatment associated with lung
diseases in children as well as adults are expected to drive the growth of
artificial ventilation and anesthesia masks market over the next seven years.
Browse Press
Release of this report:
Grand View Research has segmented the artificial
ventilation and anesthesia masks market on the basis of application:
Global Artificial Ventilation and
Anesthesia Masks Application Outlook (Market Revenue in USD Million, 2012 -
2022)
·
Artificial Ventilation and Anesthesia Masks
Market, by Application for High Risk Procedures
o
Operation Room
o
Intensive Care Units
o
Emergency Room
o
Dental
·
Artificial Ventilation and Anesthesia Masks Market, by Application
for Moderate Risk Procedures
o
Operation Room
o
Intensive Care Units
o
Emergency Room
o
Dental
·
Artificial Ventilation and Anesthesia Masks Market, by
Application for Standard Risk Procedures
o
Operation Room
o
Intensive Care Units
o
Emergency Room
o
Dental
o
Homecare
About Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
Comments
Post a Comment